Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seher Sener

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Rheumatology (Oxford, England)|April 23, 2025
Comment on: Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitisSeher Sener
Seminars in Arthritis and Rheumatism|May 4, 2025
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomesSeher Sener
International Journal of Rheumatic Diseases|August 27, 2024
Juvenile-onset mixed connective tissue disease from a different perspectiveSeher Sener
Molecular Biology Reports|April 12, 2025
Unraveling the role of IRAK1 in autoimmune rheumatic diseases: beyond genetic associationsSeher Sener
Annals of the Rheumatic Diseases|November 6, 2025
Correspondence on 'Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies' by Alabbasi et alJian Huang, Seher Sener
International Journal of Rheumatic Diseases|April 24, 2025
Key Points in the Association of Rheumatoid Arthritis With Major Adverse Cardiovascular Events and MalignanciesSeher Sener, Yusuf Ziya Sener
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2025
Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et alYusuf Ziya Sener, Seher Sener
Clinical Rheumatology|February 18, 2025
Letter to the editor: Cardiovascular risk according to biological agent exposure in patients with ankylosing spondylitis: a nationwide population-based studyYusuf Ziya Sener, Seher Sener
Paediatric Drugs|June 18, 2025
A Systematic Review of Anti-TNF and Anti-IL-6 Treatments for Pediatric Takayasu Arteritis: Addressing a Therapeutic DilemmaEzgi Deniz Batu, Seher Sener
Archives of Rheumatology|April 16, 2026
A Comprehensive Approach to QTc Interval in Rheumatoid ArthritisYusuf Ziya Şener, Seher Sener
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|April 23, 2025
Comment on: Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitisSeher Sener
Seminars in Arthritis and Rheumatism|May 4, 2025
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomesSeher Sener
International Journal of Rheumatic Diseases|August 27, 2024
Juvenile-onset mixed connective tissue disease from a different perspectiveSeher Sener
Molecular Biology Reports|April 12, 2025
Unraveling the role of IRAK1 in autoimmune rheumatic diseases: beyond genetic associationsSeher Sener
Annals of the Rheumatic Diseases|November 6, 2025
Correspondence on 'Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies' by Alabbasi et alJian Huang, Seher Sener
International Journal of Rheumatic Diseases|April 24, 2025
Key Points in the Association of Rheumatoid Arthritis With Major Adverse Cardiovascular Events and MalignanciesSeher Sener, Yusuf Ziya Sener
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2025
Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et alYusuf Ziya Sener, Seher Sener
Clinical Rheumatology|February 18, 2025
Letter to the editor: Cardiovascular risk according to biological agent exposure in patients with ankylosing spondylitis: a nationwide population-based studyYusuf Ziya Sener, Seher Sener
Paediatric Drugs|June 18, 2025
A Systematic Review of Anti-TNF and Anti-IL-6 Treatments for Pediatric Takayasu Arteritis: Addressing a Therapeutic DilemmaEzgi Deniz Batu, Seher Sener
Archives of Rheumatology|April 16, 2026
A Comprehensive Approach to QTc Interval in Rheumatoid ArthritisYusuf Ziya Şener, Seher Sener
Pageof 8